Kristen M Weishaar Selected Research

Messenger RNA (mRNA)

3/2020

Phase-I trial of survivin inhibition with EZN-3042 in dogs with spontaneous lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kristen M Weishaar Research Topics

Disease

7	Neoplasms (Cancer) 08/2023 - 07/2013
3	Lymphoma (Lymphomas) 11/2023 - 03/2020
1	Sarcoma (Soft Tissue Sarcoma) 08/2023
1	Disease Progression 10/2021
1	Osteosarcoma (Osteogenic Sarcoma) 10/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2021
1	Heart Arrest (Cardiac Arrest) 04/2010

Drug/Important Bio-Agent (IBA)

2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2022 - 06/2020
2	Proteins (Proteins, Gene)FDA Link 06/2020 - 03/2020
1	Interferon Type IIBA 08/2023
1	CytokinesIBA 08/2023
1	oclacitinibIBA 08/2023
1	toceranib phosphateIBA 03/2022
1	rabacfosadineIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021
1	Carboplatin (JM8)FDA LinkGeneric 10/2021
1	RNA (Ribonucleic Acid)IBA 10/2021
1	SurvivinIBA 03/2020
1	locked nucleic acidIBA 03/2020
1	Inhibitor of Apoptosis ProteinsIBA 03/2020
1	Antisense OligonucleotidesIBA 03/2020
1	EZN 3042IBA 03/2020
1	Messenger RNA (mRNA)IBA 03/2020
1	Viral DNAIBA 01/2018
1	SynaptophysinIBA 07/2013
1	VimentinIBA 07/2013
1	DesminIBA 07/2013
1	ChromograninsIBA 07/2013
1	Keratins (Keratin)IBA 07/2013

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 11/2023 - 03/2020
3	Therapeutics 08/2023 - 03/2021
1	CHOP protocol (VDCP protocol) 11/2023
1	Oncolytic Virotherapy 08/2023
1	Immunotherapy 08/2023
1	Radiotherapy 03/2022
1	Surgical Amputation (Amputations) 10/2021
1	Adjuvant Chemotherapy 03/2021
1	Cardiopulmonary Resuscitation (CPR) 04/2010